Bhavya Venkatesh: Talin Autoinhibition Is Required For Normal Hemostasis
Bhavya Venkatesh, Phd from The University of British Columbia, posted in LinkedIn:
”Excited to share our new publication out now in Platelets Journal
Platelets stick together to form clots using proteins known as integrins, which need to be activated in order to perform this function. Talin is an important protein that facilitates this activation, and talin activity is precisely regulated within the cell. We studied blood clotting using a mouse model that disrupts the mechanism by which talin activity is controlled, expecting to see more integrin activation, and thus faster blood clotting.
What we observed was the opposite of this, these mice showed slower clotting, and the platelets were not able to stick together properly. This suggests for the first time, that the role of talin in platelets is more complex and nuanced than previously thought, and could also be distinct from its role in other cell types.
Thank you to the Kim lab and Guy Tanentzapf at The University of British Columbia for your help and guidance, especially to Kalyan Golla.”
Read the full article here.
Title: Talin autoinhibition is required for normal hemostasis
Authors: Bhavya Venkatesh, Kalyan Golla, Felix Hong, Amanda Haage, Hugh Kim, Guy Tanentzapf
Stay updated with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia